Navigation Links
Qualitest Receives FDA Approval for Emoquette™ (.15 mg Desogestrel and .03 mg Ethinyl Estradiol), an Oral Contraceptive for Prevention of Pregnancy
Date:3/4/2011

HUNTSVILLE, Ala., March 4, 2011 /PRNewswire/ -- Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Emoquette™ (Desogestrel and Ethinyl Estradiol Tablets. 0.15mg/0.03mg, generic Ortho-Cept®) for the prevention of pregnancy in women who elect to use oral contraceptives for the prevention of pregnancy.

About Qualitest

Founded in 1983, Qualitest provides affordable, high-quality generic pharmaceuticals. Featuring a current portfolio exceeding 600 products, the company has grown significantly since its inception and is now ranked in the top ten among all suppliers of generics, based on total prescriptions filled. Qualitest is a wholly owned subsidiary of Endo Pharmaceuticals (Nasdaq: ENDP), a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics (www.endo.com).  

Forward-Looking Statements

This press release contains forward-looking statements regarding, among other things, the business combination between Endo and Qualitest, Endo's and Qualitest's financial position, results of operations, market position, product development and business strategy, as well as estimates of Endo's future total revenues, future expenses, future net income and future earnings per share.  Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may" "intend," "guidance" or similar expressions are forward-looking statements.  Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect the  business combination of the companies, future financial results and could cause actual
'/>"/>

SOURCE Qualitest Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg / 500 mg, NDC 0603-3888-20, 60 Count, Lot Numbers T150G10B, T120J10E and T023M10A and Phenobarbital Tablets, USP 32.4 mg, ND
2. Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management
3. Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
4. Ventus Medical Receives CE Mark for Provent® Sleep Apnea Therapy
5. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
6. Nile Therapeutics Receives Positive NASDAQ Panel Decision
7. Echo Therapeutics Receives Frost & Sullivans 2011 Technology Innovation Award
8. Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog®
9. Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
10. Mylan Receives Approval for Generic Version of Neurontin® Capsules
11. Elektas Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014  CASI Pharmaceuticals, Inc. (Nasdaq: ... the treatment of cancer and other diseases, announced today ... Administration (CFDA) has approved the Company,s application to conduct ... (TNBC) patients in China for ... Ken K. Ren , Ph.D., CASI,s Chief Executive Officer, ...
(Date:7/21/2014)... , July 22, 2014 Research and ... of the "Global Coronary Stents Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a ... of stainless steel, cobalt-based alloy with mechanism of ... blockages that may occur in patients after they ...
(Date:7/18/2014)... July 18, 2014  Patient engagement is a ... marketing is one of the principal groups that ... Policy groups within the pharmaceutical industry are among ... activities and initiatives to positively impact the "patient ... firm, Best Practices, LLC, identified the key support ...
Breaking Medicine Technology:CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 4Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo 2Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo 3Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC 2
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and ... Sachs Global Healthcare Conference on Tuesday, June 15 , at ... Los Angeles .  The presentation will be webcast on the following ... , ...
... Epocal, Inc., a leading edge provider of point ... Food and Drug Administration (FDA) clearance to market its new ... from the epoc System are used to evaluate acid-base status ... acidity of the blood).  The addition of lactate to the ...
Cached Medicine Technology:Epocal Announces FDA Clearance of Lactate Test 2
(Date:7/21/2014)... 22, 2014 Recently, Stwd.co.uk, a popular supplier ... wedding dresses. Additionally, the company’s chief executive officer has stated ... prices, up to 58% off. , “All our new and ... offer is launched to bring huge benefits to worldwide customers. ... cheap wedding outfits. By the way, we offer custom made ...
(Date:7/21/2014)... PowerObjects, a professional services firm 100% ... for Microsoft Dynamics CRM, has joined the prestigious ... of the most strategic Microsoft Dynamics partners from ... them in the highest echelon of the Microsoft ... Microsoft Dynamics Inner Circle have performed to a ...
(Date:7/21/2014)... (Philadelphia, PA) Patients who have a clot ... be treated with traditional blood-thinning medication or undergo ... comfortable that there is no difference in death ... more bleeding risks with the catheter procedure, according ... Medicine researchers. The study involved a review of ...
(Date:7/21/2014)... July 21, 2014 (HealthDay News) -- The "viral reservoir" ... detection and elimination, is established much earlier than previously ... new obstacles for those working to eradicate the AIDS-causing ... HIV Research Program. They said the presence of the ... a cure for a subtype of HIV, known as ...
(Date:7/21/2014)... (PRWEB) July 21, 2014 Western ... “Great College to Work For” by the Chronicle ... and also made the Honor Roll for the ... categories: Collaborative Governance, Compensation and Benefits, Confidence in ... Respect & Appreciation. , “Western University of Health ...
Breaking Medicine News(10 mins):Health News:2014 Cheap Wedding Dresses, Newest Items Offered by Professional Company Stwd.co.uk 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll 2
... the experts are happy about the significant improvement in ... discovery of a new virus carried by bats ... ,Health and veterinary experts have singled out Indonesia, ... bird flu contagion is particularly worrisome. ,FAO's ...
... that a proud person could either be truly self-confident ... California study demonstrated that people have a propensity to ... authors term authentic pride, or they link it to ... ,While authentic pride was connected to more positive personality ...
... technique, called coherent anti-Stokes Raman cattering ... sclerosis. ,The researchers have studied ... the technique. ,Myelin is the fatty sheath coating ... efficient nerve fibre conduction. In diseases such as multiple sclerosis, ...
... there's one person who's still not convinced that Britney Spears is ... her soon to be ex-hubby Kevin Federline. ,A ... Britney is 'mentally unstable', and the reason behind her breakdown earlier ... ,"He thinks she's mentally unstable and too young to ...
... correction for clubfoot, a birth defect in which the foot ... compliance and fewer complications than the traditional brace used to ... professor of orthopedic surgery at the School of Medicine, designed ... active movement, preserve muscle strength in the foot and ankle ...
... cell startlingly similar to its human counterpart will likely ... organ tissue in people, two studies reported Wednesday. ... the inner-most layer of week-old rodent embryos, will provide ... diseases and injuries, the researchers said. ,"They ...
Cached Medicine News:Health News:Avian Flu Seen in Others Birds too 2Health News:Avian Flu Seen in Others Birds too 3Health News:Pride, Even the Hubristic Kind, Allows Us to Survive 2Health News:New Innovation in Clubfoot Treatment 2Health News:New Innovation in Clubfoot Treatment 3Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 2Health News:'Missing Link' Stem Cells may Shorten Path to Therapies 3
Each handle is designed to fit a specific trephine size....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: